C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the safest and most effective dose of 5-FU
that can be given with docetaxel (Taxotere), Cisplatin and cetuximab to patients with newly
diagnosed locally advanced squamous cell carcinoma of the head and neck. We will also be
studying the toxicity of this regimen of 4 drugs and the tumor response.